#724 Kidney transplant outcomes in highly sensitized patients with preformed donor-specific antibodies using a DELISTING strategy
Sign Up to like & getrecommendations! Published in 2025 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaf116.0824
Abstract: Highly sensitized patients represent a significant challenge in kidney transplantation (KT) due to the limited availability of compatible donors and the high risk of antibody-mediated rejection. In this context, the delisting of forbidden HLA antigens… read more here.
Keywords: specific antibodies; preformed donor; transplant; donor specific ... See more keywords
Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
Sign Up to like & getrecommendations! Published in 2021 at "Transplantation Direct"
DOI: 10.1097/txd.0000000000001180
Abstract: Background. The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol for DSA-positive recipients. Methods. A Japanese nationwide survey was performed to investigate… read more here.
Keywords: transplant recipients; rituximab desensitization; liver transplant; desensitization ... See more keywords
Preformed donor‐specific antibodies do not affect the 1‐year allograft survival in living donor liver transplantation
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Transplantation"
DOI: 10.1111/ctr.13244
Abstract: The effect of preformed donor‐specific antibodies (DSAs) on liver transplantation (LT) remains unclear, especially in the field of living donor LT (LDLT). Herein, we evaluated the prevalence of preformed DSAs and their effect on graft… read more here.
Keywords: year; preformed dsas; transplantation; preformed donor ... See more keywords